Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance. | Cell Stress;6(11): 89-92, 2022 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance.

Patiño-Escobar, Bonell; Ferguson, Ian D; Wiita, Arun P.

Affiliation

Patiño-Escobar B; Dept. of Laboratory Medicine, University of California, San Francisco, CA, USA.
Ferguson ID; Dept. of Laboratory Medicine, University of California, San Francisco, CA, USA.
Wiita AP; Program in Cancer Biology, Stanford University School of Medicine, CA, USA.

Cell Stress ; 6(11): 89-92, 2022 Nov.

Article in En | MEDLINE | ID: mdl-36311892

Key words

CAR-T; drug resistance; immunotherapy; myeloma; proteomics; surfaceome

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cell Stress Year: 2022 Type: Article Affiliation country: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cell Stress Year: 2022 Type: Article Affiliation country: United States